-
Mashup Score: 12
ROCHESTER, Minn. — Mayo Clinic’s Board of Trustees has approved Bold. Forward. Unbound. in Rochester, a multiyear strategic initiative that […]
Source: newsnetwork.mayoclinic.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2World's Best Hospitals 2023 - Top 250 - 1 year(s) ago
World’s Best Hospitals 2023 – Top 250
Source: NewsweekCategories: Infectious Disease, Latest HeadlinesTweet-
World's Best Hospitals 2023 - Top 250 https://t.co/SkzyUxAQiv
-
-
Mashup Score: 22023 AST Virtual Run and Fitness Challenge - 1 year(s) ago
Let’s complete a mile for every transplant in 2022.
Source: Charity FootprintsCategories: Infectious Disease, Latest HeadlinesTweet-
Come and join me at 2023 AST Virtual Run and Fitness Challenge in support of American Society of Transplantation: #GetFitGiveBack https://t.co/BXkeRir0di
-
-
Mashup Score: 0Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19 - PubMed - 1 year(s) ago
COVID-19 convalescent plasma (CCP) is a safe and effective treatment for COVID-19 in immune compromised (IC) patients. IC patients have a higher risk of persistent infection, severe disease and death from COVID-19. Despite the continued clinical use of CCP to treat IC patients, the optimal dose, fre …
Source: PubMedCategories: Infectious Disease, Latest HeadlinesTweet-
Expert opinion on the use of COVID-19 convalescent plasma for immunocompromised hosts during the Omicron subvariants era. @CIDJournal Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19 https://t.co/0LAPwMuEe4
-
-
Mashup Score: 22022 COP Donation Derby - 1 year(s) ago
DONATE NOW
Categories: Infectious Disease, Latest HeadlinesTweet-
I donated to #AST @AST_info to support its mission. Join in this effort by clicking the link below. The COP derby is ON! #IDCOP @AST_IDCOP let us get going!!! https://t.co/QfSeVNO5F2 https://t.co/DLb0Qv62ay
-
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Infectious Disease, Latest HeadlinesTweet-
This data on 657 SOT patients with COVID-19 showed: risk of severe outcome is higher among those with multiple comorbidity, while the risk is reduced among fully vaccinated patients. https://t.co/91TUgcYl0p
-
-
Mashup Score: 1pendingpublications - 2 year(s) ago
Pending Publication
Source: apps.crossref.orgCategories: Infectious Disease, Latest HeadlinesTweet-
Thanks to Drs. Robin Avery and Veronica Dioverti for their editorial highlighting the relevance of our study on #Bebtelovimab and #Paxlovid. https://t.co/sFuapzlQZG
-
-
Mashup Score: 3
This real-world retrospective cohort study of 3,607 high-risk patients with mild to moderate coronavirus-2019 disease demonstrates that the rates of severe dise
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
The study highlighted differences in characteristics of patients treated with #bebtelovimab vs #Paxlovid. Immunocompromised and older patients and those with multiple comorbidity were treated with Bebtelovimab. Despite this, outcome is favorable. https://t.co/JLAdpldqpY
-
-
Mashup Score: 2
This real-world retrospective cohort study of 3,607 high-risk patients with mild to moderate coronavirus-2019 disease demonstrates that the rates of severe dise
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
Real-world study of 3,607 high-risk patients with mild to moderate COVID-19: rates of severe disease progression by day 30 was not significantly different between bebtelovimab (1.4%) or oral nirmatrelvir-ritonavir (1.2%) treatment. https://t.co/JLAdpldqpY
-
-
Mashup Score: 4Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Infectious Disease, Latest HeadlinesTweet-
Early MAbs Rx reduce the risk of severe COVID-19 in SOT patients. Vaccine is protective. Omicron outcomes better than Delta. BUT… a higher number of comorbidity still predicts severe disease progression. https://t.co/91TUgcYl0p https://t.co/vUezGNozwJ
-
Mayo Clinic Board of Trustees approves plans to transform healthcare, improve experience for staff and patients, redesign Rochester campus - Mayo Clinic News Network https://t.co/F0waR3JNdA